Adriamycin-resistant breast cancer cells produce exosomal miR-222, which targets Phosphatase and Tensin Homolog (PTEN) gene, and activates the Akt pathway, leading to macrophage polarization to M2 and tumor progression [50]. The gene discussed is AKT1; the disease is neoplasm.